McElhenny Sheffield Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $420K | Hold |
2,263
| – | – | 0.11% | 66 |
|
|
2025
Q1 | $474K | Sell |
2,263
-6
| -0.3% | -$1.26K | 0.18% | 54 |
|
|
2024
Q4 | $403K | Buy |
2,269
+17
| +0.8% | +$3.02K | 0.14% | 69 |
|
|
2024
Q3 | $445K | Buy |
2,252
+18
| +0.8% | +$3.56K | 0.15% | 66 |
|
|
2024
Q2 | $380K | Hold |
2,234
| – | – | 0.13% | 66 |
|
|
2024
Q1 | $395K | Sell |
2,234
-2
| -0.1% | -$354 | 0.14% | 67 |
|
|
2023
Q4 | $351K | Hold |
2,236
| – | – | 0.14% | 65 |
|
|
2023
Q3 | $333K | Hold |
2,236
| – | – | 0.17% | 66 |
|
|
2023
Q2 | $301K | Sell |
2,236
-6,777
| -75% | -$911K | 0.13% | 70 |
|
|
2023
Q1 | $1.44M | Sell |
9,013
-1,344
| -13% | -$214K | 0.76% | 19 |
|
|
2022
Q4 | $1.67M | Sell |
10,357
-6,737
| -39% | -$1.09M | 0.77% | 15 |
|
|
2022
Q3 | $2.29M | Buy |
17,094
+33
| +0.2% | +$4.43K | 1.75% | 8 |
|
|
2022
Q2 | $2.61M | Buy |
17,061
+1,439
| +9% | +$220K | 1.22% | 9 |
|
|
2022
Q1 | $2.53M | Sell |
15,622
-555
| -3% | -$90K | 0.88% | 12 |
|
|
2021
Q4 | $2.19M | Buy |
16,177
+280
| +2% | +$37.9K | 0.82% | 14 |
|
|
2021
Q3 | $1.72M | Buy |
+15,897
| New | +$1.72M | 0.78% | 13 |
|